Header Logo

Connection

Jacob Rotmensch to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications Jacob Rotmensch has written about Maximum Tolerated Dose.
Jacob Rotmensch
Connection Strength
0.014
Maximum Tolerated Dose
  1. Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies. Gynecol Oncol. 2004 Mar; 92(3):801-5.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.